A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2004
10/06/2004	EP1463761A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma
10/06/2004	EP1463759A1 Ligand for g-protein coupled receptor gpr43 and uses thereof
10/06/2004	EP1463758A2 Mammal prolactin variants
10/06/2004	EP1463756A2 Secreted proteins
10/06/2004	EP1463755A2 Recombinant polypeptides
10/06/2004	EP1463754A2 Cystine-knot fold protein
10/06/2004	EP1463747A2 Novel antibodies that bind to antigenic polypeptides,nucleic acids encodings the antigens, and methodes of use
10/06/2004	EP1463731A1 Dibenzodiazepine derivates, their preparation and use
10/06/2004	EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function
10/06/2004	EP1463719A2 Eponemycin and epoxomicin analogs and uses thereof
10/06/2004	EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004	EP1463707A2 A group of novel anti-cancer compounds with specific structure
10/06/2004	EP1463527A2 The use of gammaglobulin for the treatment of immune-mediated diseases
10/06/2004	EP1463509A1 Type 4 phosphodiesterase inhibitors and uses thereof
10/06/2004	EP1463498A1 Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
10/06/2004	EP1303632B1 Galactomannan oligosaccharides and methods for the production and use thereof
10/06/2004	EP1282395B1 Use of ellagic acid as anti-pollution cosmetic agent
10/06/2004	EP1248787B1 NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
10/06/2004	EP1210325B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
10/06/2004	EP1202743B1 Pharmaceutical and cosmetic compositions comprising cod serine proteases and their pharmaceutical and cosmetic use
10/06/2004	EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
10/06/2004	EP1135163B1 Topical compositions comprising ascomycins
10/06/2004	EP1133284B1 A process for the preparation of crystalline particles
10/06/2004	EP1101112B1 Leptin-mediated gene-induction
10/06/2004	EP1096954B1 Adjuvant and vaccine compositions containing monophosphoryl lipid a
10/06/2004	EP1073464B1 Monoclonal antibodies with reduced immunogenicity
10/06/2004	EP0971945B1 Method for preparation of conjugate vaccines using uronium salt
10/06/2004	EP0876498B1 Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv
10/06/2004	EP0869810B1 Cyclosporin-containing soft capsule preparations
10/06/2004	EP0868425B1 Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
10/06/2004	EP0821551B1 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor
10/06/2004	CN2645668Y Plaster for allergic rhinitis
10/06/2004	CN1535312A PUFA polyketide synthase systems and uses thereof
10/06/2004	CN1535282A Ganalioside-associated recombinant antibodies and use thereof in diagnosis and treatment of tumours
10/06/2004	CN1535281A Peptides and related molecules that bind to TALL-1
10/06/2004	CN1535168A Controlled release composition and method of producing the same
10/06/2004	CN1535153A Method of implanting heavy method such as nobel metal, E.G. glod, and metal for use in implantation
10/06/2004	CN1535151A Novel anti-infectives
10/06/2004	CN1535147A Azolylcarbynol derivatives of aryl (or heteroaryl) for treatment of respiratory diseases
10/06/2004	CN1534017A N-(2-phenyl-4-amino-batyl)-1-naphthol carboxy amide kind compound used as neuropeptide-1-acceptor antagonistic agent
10/06/2004	CN1533807A High dosage recombination human alpha interferon oral tablet and its manufacturing method
10/06/2004	CN1533773A Application of N-acetylglucosamine in The preparation of medicine for treating local injure or whole body syndrome due to self immune reaction
10/06/2004	CN1169966C Isolated, tyrosinase derived peptides and uses thereof
10/06/2004	CN1169839C Wolfberry polysaccharide and its prepn. and application
10/06/2004	CN1169835C Human B lymphocyte stimulating factor mutant and constructing method and coding gene thereof
10/06/2004	CN1169829C Non-T cell conjugating peptide and its use
10/06/2004	CN1169808C 'Beta'-carboline compound
10/06/2004	CN1169578C Beaver thymosin injection and its prepn
10/06/2004	CN1169568C External use medicine for treating allergic nasitis and preparing process thereof
10/06/2004	CN1169549C Health preparation with body fragrance and immunological regulatory function
10/05/2004	US6800734 Membrane proteins, such as kinase, permease, mannosyltransferase and endoflagellin used to induce a protective immune response in animals; vaccines
10/05/2004	US6800654 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/05/2004	US6800645 Substituted azabicyclic compounds
10/05/2004	US6800644 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
10/05/2004	US6800633 Pyrrolo[2,3d]pyrimidine compositions and their use
10/05/2004	US6800632 Bicyclic inhibitors of glycogen synthase kinase 3
10/05/2004	US6800626 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc.
10/05/2004	US6800624 Sulfonamide and sulfamide substituted imidazoquinolines
10/05/2004	US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells
10/05/2004	US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives
10/05/2004	US6800613 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
10/05/2004	US6800469 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens
10/05/2004	US6800441 Heparanase specific molecular probes and their use in research and medical applications
10/05/2004	CA2282834C Novel hexanoic acid derivatives
10/04/2004	CA2463115A1 Anti-inflammatory composition
09/2004
09/30/2004	WO2004083392A2 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
09/30/2004	WO2004083372A2 Modulators of the notch signaling pathway immobilized on particles for modifying immune responses
09/30/2004	WO2004083249A2 Antibodies against human il-21 receptor and uses therefor
09/30/2004	WO2004083231A2 Use of peptide ligands for plasma membrane receptors or similar for mitochondrial activity modulation
09/30/2004	WO2004083188A1 Water-soluble phenylpyridazine derivative and medicine containing the same
09/30/2004	WO2004083184A1 Receptor antagonist
09/30/2004	WO2004083182A1 Cathepsin s inhibitors
09/30/2004	WO2004083167A1 Sulfamide derivative and medicinal composition thereof
09/30/2004	WO2004082710A1 Treatment of allergic diseases using a modulator of the notch signaling pathway
09/30/2004	WO2004082688A1 Phosphatidylglycerol (pg) receptor agonists and antagonists
09/30/2004	WO2004082681A1 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation- and ummunologically-mediated diseases
09/30/2004	WO2004064912A8 An otorhinological delivery device
09/30/2004	WO2004047725A3 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
09/30/2004	WO2004043331A3 Dermastick thickened ointment
09/30/2004	WO2003097806A3 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/30/2004	WO2003088903A3 Compounds, compositions, and methods
09/30/2004	WO2003080105A9 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
09/30/2004	WO2003072740A3 Novel type-1 cytokine receptor glm-r
09/30/2004	WO2003068197A8 Method for systemic drug delivery through the nail
09/30/2004	WO2003024396A3 Dry powder medicament formulations
09/30/2004	US20040192943 Nf-kappab inhibitors
09/30/2004	US20040192916 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents
09/30/2004	US20040192757 Reacting a 2-pyrrolidinone with alpha-keto acid; cyclization, ammonolysis , catalytic hydrogenation
09/30/2004	US20040192752 Anti-HIV pyrazole derivatives
09/30/2004	US20040192750 Antiproliferative agents; anticancer agents; neurodegenerative agents sexual disorders; antidiabetic agents; urogenital disorders; antidiabetic agents; obesity; muscular disorders; aftertreatment surgery; autoimmune disease
09/30/2004	US20040192746 Anticancer agents; central nervous system disorders; sexual disorders; antidiabetic agents; obesity; muscular disorders; alopecia; sepsis; autoimmune disease
09/30/2004	US20040192733 Hydroxamic acid derivatives
09/30/2004	US20040192720 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
09/30/2004	US20040192717 Salts of guanidine derivatives and pharmaceutical preparations consisting thereof
09/30/2004	US20040192716 Mixture with 2-amino-1,3-propanediol and excipients; synergistic mixture; concurrent administering
09/30/2004	US20040192711 Kinase inhibitor; therapy for leukemia, lymphoma; skin cancer; autoimmune diseases; antiinflammatory agents; sunscreen agents
09/30/2004	US20040192709 7-oxo-pyridopyrimidines (II)
09/30/2004	US20040192701 Phenlypyridine carbonyl piperazine derivative
09/30/2004	US20040192596 Therapeutic fibrin-derived peptides and uses thereof
09/30/2004	US20040192589 Production of high molecular mass lectins

1 ... 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 ... 1172